{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T04:20:45Z","timestamp":1727842845523},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Perioperative chemotherapy (PeriCh) is the current standard of care for stage II\/III gastric cancer tumors in Europe. However, when it concerns patients who endure complications during PeriCh it is unclear if it increases the risk of postoperative complications and other poorer surgical outcomes. We aim to demonstrate if there is an association between having complications during PeriCh and postoperative complications and histopathological response.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We conducted a retrospective, transversal, and observational study, including all patients with diagnosed gastric cancer who underwent PeriCh followed by surgical resection during the period of eight years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We included 80 patients with a median age of 64.0years (min 24, max 78). Eighty-eight-point eight percent ended the chemotherapy regime proposed, with a median duration of 42 days, and were also submitted to gastric resection: 58.8% total gastrectomy and 41.2% distal gastrectomy. Twelve-point five percent of the patients had no complications during the PeriCh period and 16.3% had &gt;2 complications. Twenty-five percent of patients had a histological response of &lt;10% of tumor burden, but in 41.3% only regression of &lt;50% could be obtained. No significant association was found between complications during PeriCh and adverse surgical outcomes (<jats:italic toggle=\"yes\">P<\/jats:italic> = .497). Patients with complications during PeriCh had slightly higher median time difference from end of PeriCh until surgery, but with no statistical significance (<jats:italic toggle=\"yes\">P<\/jats:italic> = .575).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In our sample, the existence of association between complications during PeriCh and postoperative complications or histological response was not demonstrated.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/j.pbj.0000000000000180","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T21:00:31Z","timestamp":1671138031000},"page":"e180","update-policy":"http:\/\/dx.doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Impact of perioperative chemotherapy in the treatment of patients with gastric cancer"],"prefix":"10.1097","volume":"7","author":[{"given":"Telma","family":"Fonseca","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Porto, Portugal,"},{"name":"General Surgery Departament, Centro Hospitalar e Universit\u00e1rio do S\u00e3o Jo\u00e3o, Porto, Portugal."}]},{"given":"Mariana","family":"Coimbra","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Porto, Portugal,"}]},{"given":"Hugo","family":"Santos-Sousa","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Porto, Portugal,"},{"name":"General Surgery Departament, Centro Hospitalar e Universit\u00e1rio do S\u00e3o Jo\u00e3o, Porto, Portugal."}]},{"given":"Elisabete","family":"Barbosa","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Porto, Portugal,"},{"name":"General Surgery Departament, Centro Hospitalar e Universit\u00e1rio do S\u00e3o Jo\u00e3o, Porto, Portugal."}]},{"given":"Jos\u00e9","family":"Barbosa","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Porto, Portugal,"},{"name":"General Surgery Departament, Centro Hospitalar e Universit\u00e1rio do S\u00e3o Jo\u00e3o, Porto, Portugal."}]}],"member":"276","published-online":{"date-parts":[[2022,11]]},"reference":[{"key":"R1-20241001","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","year":"2018","journal-title":"CA Cancer J Clin."},{"key":"R2-20241001","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","year":"2013","journal-title":"Eur J Cancer."},{"key":"R3-20241001","first-page":"931","article-title":"EUROCARE-4","volume":"45","year":"2009","journal-title":"Survival of cancer patients diagnosed in 1995\u20131999. Results and commentary. Eur J Cancer."},{"key":"R4-20241001","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1200\/JCO.2004.08.154","article-title":"Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer\u2014pooled analysis from three multicenter, randomized, controlled trials using individual patient data","volume":"22","year":"2004","journal-title":"J Clin Oncol."},{"key":"R5-20241001","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","year":"2010","journal-title":"CA Cancer J Clin."},{"key":"R7-20241001","article-title":"Progress in the treatment of advanced gastric cancer","volume":"39","year":"2017","journal-title":"Tumor Biol."},{"key":"R8-20241001","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1053\/j.gastro.2018.05.026","article-title":"Cost effectiveness of gastric cancer screening according to race and ethnicity","volume":"155","year":"2018","journal-title":"Gastroenterology."},{"key":"R9-20241001","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/j.gastro.2018.04.026","article-title":"Endoscopic screening in Asian countries is associated with reduced gastric cancer mortality: a meta-analysis and systematic review","volume":"155","year":"2018","journal-title":"Gastroenterology."},{"key":"R10-20241001","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/jjco\/hyy077","article-title":"Systematic Review Group and Guideline Development Group for Gastric Cancer Screening Guidelines. Update version of the Japanese Guidelines for Gastric Cancer Screening","volume":"48","year":"2018","journal-title":"Jpn J Clin Oncol."},{"key":"R11-20241001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","year":"2006","journal-title":"N Engl J Med."},{"key":"R12-20241001","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/07357907.2014.911877","article-title":"An updated meta-analysis of randomized controlled trial assessing the effect of neoadjuvant chemotherapy in advanced gastric cancer","volume":"32","year":"2014","journal-title":"Cancer Invest."},{"key":"R13-20241001","doi-asserted-by":"crossref","first-page":"e86941","DOI":"10.1371\/journal.pone.0086941","article-title":"Neoadjuvant chemotherapy followed by surgery versus surgery alone for gastric carcinoma: systematic review and meta-analysis of randomized controlled trials","volume":"9","year":"2014","journal-title":"PLoS One."},{"key":"R14-20241001","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/apm.12642","article-title":"Histopathological regression of gastric adenocarcinoma after neo-adjuvant therapy: a critical review","volume":"125","year":"2017","journal-title":"APMIS."},{"key":"R15-20241001","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1245\/s10434-011-2165-6","article-title":"Posttherapy nodal status, not graded histologic response, predicts survival after neoadjuvant chemotherapy for advanced gastric cancer","volume":"19","year":"2012","journal-title":"Ann Surg Oncol."},{"key":"R16-20241001","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1245\/s10434-012-2267-9","article-title":"Surgical complications in gastric cancer patients preoperatively treated with chemotherapy: their risk factors and clinical relevance","volume":"19","year":"2012","journal-title":"Ann Surg Oncol."},{"key":"R17-20241001","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/dote.12067","article-title":"Increasing toxicity during neoadjuvant radiochemotherapy as positive prognostic factor for patients with esophageal carcinoma","volume":"27","year":"2014","journal-title":"Dis Esophagus."},{"key":"R18-20241001","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1245\/s10434-015-4423-5","article-title":"High-grade toxicity to neoadjuvant treatment for upper gastrointestinal carcinomas: what is the impact on perioperative and oncologic outcomes?","volume":"22","year":"2015","journal-title":"Ann Surg Oncol."},{"key":"R19-20241001","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1245\/s10434-006-9198-2","article-title":"Impact ofinduction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junction","volume":"14","year":"2007","journal-title":"Ann Surg Oncol."},{"key":"R20-20241001","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","year":"2004","journal-title":"Ann Surg."},{"key":"R21-20241001","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/cncr.11660","article-title":"Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy","volume":"98","year":"2003","journal-title":"Cancer."},{"key":"R22-20241001","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12885-018-4027-0","article-title":"Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysis","volume":"18","year":"2018","journal-title":"BMC Cancer."},{"key":"R23-20241001","first-page":"201","article-title":"Neoadjuvant chemotherapy brings more survival benefits than postoperative chemotherapy for resectable gastric cancer: a meta-analysis of randomized controlled trials","volume":"24","year":"2019","journal-title":"J BUON."},{"key":"R24-20241001","first-page":"120","article-title":"Neoadjuvant chemotherapy in advanced gastric and esophago-gastric cancer","volume":"51","year":"2018","journal-title":"Meta-analysis of randomized trials. Int J Surg."},{"key":"R25-20241001","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1186\/s12885-016-2667-5","article-title":"Which is better for gastric cancer patients, perioperative or adjuvant chemotherapy: a meta-analysis","volume":"16","year":"2016","journal-title":"BMC Cancer [Internet]."},{"key":"R26-20241001","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1457496915577021","article-title":"Comparative investigation of postoperative complications in patients with gastroesophageal junction cancer treated with preoperative chemotherapy or surgery alone","volume":"105","year":"2016","journal-title":"Scand J Surg."},{"key":"R27-20241001","first-page":"1","article-title":"The efficacy and safety of (Neo)adjuvant therapy for gastric cancer: a network meta-analysis","volume":"11","year":"2019","journal-title":"Cancers (Basel)."},{"key":"R28-20241001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12957-015-0444-6","article-title":"Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy","volume":"13","year":"2015","journal-title":"World J Surg Oncol."},{"key":"R29-20241001","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijsu.2018.02.023","article-title":"Prospective cohort study of neoadjuvant therapy toxicity in the treatment of oesophageal adenocarcinoma","volume":"52","year":"2018","journal-title":"Int J Surg."},{"key":"R30-20241001","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ctrv.2018.06.012","article-title":"Locally advanced gastro-oesophageal cancer: Recent therapeutic advances and research directions","volume":"69","year":"2018","journal-title":"Cancer Treat Rev."},{"key":"R31-20241001","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00066-009-2037-1","article-title":"High-grade acute organ toxicity during preoperative radiochemotherapy as positive predictor for complete histopathologic tumor regression in multimodal treatment of locally advanced rectal cancer","volume":"186","year":"2010","journal-title":"Strahlenther Onkol."},{"key":"R32-20241001","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3748\/wjg.v24.i2.257","article-title":"Timing of surgery after neoadjuvant chemotherapy for gastric cancer: Impact on outcomes","volume":"24","year":"2018","journal-title":"World J Gastroenterol."}],"container-title":["Porto Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/j.pbj.0000000000000180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T19:03:02Z","timestamp":1727809382000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/j.pbj.0000000000000180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/j.pbj.0000000000000180","relation":{},"ISSN":["2444-8664"],"issn-type":[{"type":"electronic","value":"2444-8664"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"2020-06-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}